Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(7 sites)
United States
Mayo Clinic - Scottsdale Arizona, Scottsdale, Arizona Mayo Clinic, Jacksonville, Florida Indiana University, Indianapolis, Indiana Mayo Clinic - Rochester Minnesota, Rochester, Minnesota Memorial Sloan Kettering Cancer Center, New York, New York University of Pennsylvania - Perelman Center for Advanced Medicine - Penn Urology, Philadelphia, Pennsylvania MD Anderson Cancer Center - Genitourinary (GU) Cancer Center, Houston, Texas